Old blood as good as new for transfusion: study

Image
Press Trust of India Toronto
Last Updated : Oct 25 2016 | 2:42 PM IST
Using fresh blood for transfusions may not boost patient survival, according to a new study which contradicts the common perception that stored blood could be harmful.
The study of about 31,500 patients at six hospitals in four countries showed that having a transfusion with the freshest blood did not reduce the proportion of patients who died in hospital.
"It is been a contentious issue, but our study finally puts an end to the question about whether stored blood could be harmful and fresher blood would be better," said lead author Nancy Heddle, from McMaster University in Canada.
"Our study provides strong evidence that transfusion of fresh blood does not improve patient outcomes, and this should reassure clinicians that fresher is not better," said Heddle.
She added that the results are also good news for blood suppliers worldwide as having a supply of stored blood helps to ensure that blood is available when a patient needs it.
The 31,497 adult patients studied were at hospitals in Australia, Canada, Israel and the US. The mortality rate was 9.1 per cent with people receiving the freshest blood, and 8.7 per cent among those receiving the oldest blood.
There was no significant difference when looking at the patient's blood type, diagnosis, hospital or country.
More than 40 studies published earlier have failed to adequately answer the question about whether the freshest blood was best, said John Eikelboom, from McMaster.
"Blood transfusions are a common medical intervention," he said.
"Advances in blood storage now allow blood to be stored up to 42 days before transfusion and the usual practice is to use up the blood that has been in storage the longest," he added.
"However there are biochemical, structural and functional changes in the blood during storage, there had been concerns about the use of 'older' blood. This study reassures us that ageing is not bad - even for blood," he said.
The study was published in the New England Journal of Medicine.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Oct 25 2016 | 2:42 PM IST

Next Story